Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise, AI biotech’s futurenews2025-04-01T14:34:50+00:00April 1st, 2025|Endpoints News|
La derecha en EE. UU. sigue defendiendo a la ivermectinanews2025-04-01T14:33:37+00:00April 1st, 2025|The New York Times|
Chemistry courses to be shut down at the University of Bradfordnews2025-04-01T14:32:00+00:00April 1st, 2025|Chemistry World|
Prazer Therapeutics raises $20M; Carisma lets go of most staffnews2025-04-01T14:19:29+00:00April 1st, 2025|Endpoints News|
Pressure on Europe industrials rises as default rate remains highnews2025-04-01T12:43:00+00:00April 1st, 2025|Independent Commodity Intelligence Services (ICIS)|
Taiwan’s CPDC Apr capro contracts fall on weak upstreamnews2025-04-01T12:22:00+00:00April 1st, 2025|Independent Commodity Intelligence Services (ICIS)|
Plant status: South Korea’s BASF plans PA66 plant maintenancenews2025-04-01T12:15:00+00:00April 1st, 2025|Independent Commodity Intelligence Services (ICIS)|
Firings sweep across FDA, gutting leadership and whole officesnews2025-04-01T12:00:48+00:00April 1st, 2025|Endpoints News|
Talkspace makes AI therapy podcasts for patientsnews2025-04-01T12:00:19+00:00April 1st, 2025|Endpoints News|
Europe MTBE spot prices increase due to higher gasoline valuesnews2025-04-01T11:42:00+00:00April 1st, 2025|Independent Commodity Intelligence Services (ICIS)|
